NeuroOne Medical Technologies Co. (NASDAQ:NMTC) Short Interest Down 37.1% in January

Posted by Teresa Graham on Jan 29th, 2025

NeuroOne Medical Technologies Co. (NASDAQ:NMTC – Get Free Report) saw a significant decrease in short interest in January. As of January 15th, there was short interest totalling 70,300 shares, a decrease of 37.1% from the December 31st total of 111,800 shares. Approximately 0.3% of the company’s shares are short sold. Based on an average trading volume of 173,400 shares, the days-to-cover ratio is presently 0.4 days.

NeuroOne Medical Technologies Price Performance

Shares of NMTC traded up $0.14 during midday trading on Wednesday, hitting $1.29. The stock had a trading volume of 48,894 shares, compared to its average volume of 287,264. The company has a 50 day simple moving average of $0.86 and a two-hundred day simple moving average of $0.86. NeuroOne Medical Technologies has a twelve month low of $0.55 and a twelve month high of $1.59. The firm has a market cap of $39.87 million, a price-to-earnings ratio of -2.84 and a beta of 0.41.

NeuroOne Medical Technologies (NASDAQ:NMTC – Get Free Report) last released its quarterly earnings data on Tuesday, December 17th. The company reported ($0.11) EPS for the quarter. NeuroOne Medical Technologies had a negative net margin of 356.76% and a negative return on equity of 407.04%.

Hedge Funds Weigh In On NeuroOne Medical Technologies

An institutional investor recently raised its position in NeuroOne Medical Technologies stock. Geode Capital Management LLC increased its holdings in shares of NeuroOne Medical Technologies Co. (NASDAQ:NMTC – Free Report) by 9.6% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 283,855 shares of the company’s stock after buying an additional 24,972 shares during the quarter. Geode Capital Management LLC owned 0.92% of NeuroOne Medical Technologies worth $281,000 at the end of the most recent reporting period. 16.07% of the stock is currently owned by institutional investors.

NeuroOne Medical Technologies Company Profile

(Get Free Report)

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.